Compare TTK HEALTHCARE with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE AUROBINDO PHARMA TTK HEALTHCARE/
AUROBINDO PHARMA
 
P/E (TTM) x 10.8 18.5 58.1% View Chart
P/BV x 1.6 4.0 39.0% View Chart
Dividend Yield % 1.0 0.3 376.3%  

Financials

 TTK HEALTHCARE   AUROBINDO PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
AUROBINDO PHARMA
Mar-19
TTK HEALTHCARE/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,215830 146.4%   
Low Rs610527 115.7%   
Sales per share (Unadj.) Rs444.4333.9 133.1%  
Earnings per share (Unadj.) Rs17.240.4 42.7%  
Cash flow per share (Unadj.) Rs27.651.8 53.4%  
Dividends per share (Unadj.) Rs5.002.50 200.0%  
Dividend yield (eoy) %0.50.4 148.7%  
Book value per share (Unadj.) Rs177.9237.1 75.1%  
Shares outstanding (eoy) m14.13585.91 2.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.12.0 101.1%   
Avg P/E ratio x52.916.8 314.7%  
P/CF ratio (eoy) x33.013.1 251.9%  
Price / Book Value ratio x5.12.9 179.2%  
Dividend payout %29.06.2 468.0%   
Avg Mkt Cap Rs m12,894397,569 3.2%   
No. of employees `0002.317.9 12.9%   
Total wages/salary Rs m1,30725,849 5.1%   
Avg. sales/employee Rs Th2,715.710,956.9 24.8%   
Avg. wages/employee Rs Th565.31,447.7 39.0%   
Avg. net profit/employee Rs Th105.41,324.3 8.0%   
INCOME DATA
Net Sales Rs m6,279195,636 3.2%  
Other income Rs m781,553 5.0%   
Total revenues Rs m6,356197,189 3.2%   
Gross profit Rs m49639,519 1.3%  
Depreciation Rs m1476,680 2.2%   
Interest Rs m342,626 1.3%   
Profit before tax Rs m39331,767 1.2%   
Minority Interest Rs m027 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-881 0.0%   
Tax Rs m1497,269 2.0%   
Profit after tax Rs m24423,645 1.0%  
Gross profit margin %7.920.2 39.1%  
Effective tax rate %37.922.9 165.8%   
Net profit margin %3.912.1 32.1%  
BALANCE SHEET DATA
Current assets Rs m2,717153,645 1.8%   
Current liabilities Rs m1,571120,429 1.3%   
Net working cap to sales %18.317.0 107.5%  
Current ratio x1.71.3 135.6%  
Inventory Days Days32135 23.8%  
Debtors Days Days4764 73.2%  
Net fixed assets Rs m991103,909 1.0%   
Share capital Rs m141586 24.1%   
"Free" reserves Rs m2,373138,322 1.7%   
Net worth Rs m2,514138,908 1.8%   
Long term debt Rs m31,800 0.2%   
Total assets Rs m4,158264,544 1.6%  
Interest coverage x12.613.1 96.3%   
Debt to equity ratio x00 10.4%  
Sales to assets ratio x1.50.7 204.2%   
Return on assets %6.79.9 67.2%  
Return on equity %9.717.0 56.9%  
Return on capital %16.923.8 71.1%  
Exports to sales %3.649.6 7.2%   
Imports to sales %0.518.8 2.6%   
Exports (fob) Rs m22597,091 0.2%   
Imports (cif) Rs m3136,741 0.1%   
Fx inflow Rs m22597,316 0.2%   
Fx outflow Rs m7140,589 0.2%   
Net fx Rs m15456,727 0.3%   
CASH FLOW
From Operations Rs m17316,220 1.1%  
From Investments Rs m97-28,768 -0.3%  
From Financial Activity Rs m-30719,191 -1.6%  
Net Cashflow Rs m-386,656 -0.6%  

Share Holding

Indian Promoters % 65.4 54.1 120.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 8.0 46.5%  
FIIs % 5.2 27.7 18.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 10.2 252.9%  
Shareholders   12,723 69,601 18.3%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ORCHID PHARMA  CIPLA  TORRENT PHARMA  SUVEN LIFE SCIENCES  WYETH  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Apr 16, 2021 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - CIPLA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS